Mira Pharmaceuticals, Inc.
MIRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001904286
No open-market purchases or sales by Mira Pharmaceuticals, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $2.19M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 26
- 13F valueReported value at the end of Q2 2026
- $2.19M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding MIRA, Q2 2026
No superinvestor reported holding MIRA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Mira Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 (view filing) | Nov 19-20 | 8 daysLate | Aminov ErezChief Executive Officer | SSale | −100.0K | $1.34 | −$133.6K | −8.6%1.06M after | 2 lots10b5-1 |
| Aug 30, 2024 (view filing)4:05 PM ET | Aug 28 | 2 days | Bay Shore Trust and 1 other10% Owner | SSale | −200.0K | $1.96 | −$392.0K | −7.3%2.54M after | |
| May 22, 2024 (view filing) | May 21 | 1 day | Aminov ErezChief Executive Officer | PPurchase | +8.70K | $0.9398 | +$8.18K | +2.3%382.2K after | 8 lots |
| Dec 27, 2023 (view filing)5:33 PM ET | Nov 20-Dec 11 | 37 daysLate | Bay Shore Trust and 1 other10% Owner | SSale | −238.1K | $3.05 | −$726.1K | −26.5%660.0K after | 22 lots |
| Aug 24, 2023 (view filing)5:38 PM ET | Aug 7 | 17 daysLate | Cappy George and 1 other10% Owner | PPurchase | +119.0K | $7.00 | +$833.3K | +4.3%2.86M after | |
| Aug 4, 2023 (view filing)1:42 PM ET | Aug 2 | 2 days | Cappy George and 1 other10% Owner | PPurchase | +157.2K | $7.00 | +$1.10M | +6.1%2.74M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Mira Pharmaceuticals, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 751,801 | $712.0K | 0.00% | +57,889+8.3% | Added |
| Cross Staff Investments Inc | 359,401 | $340.2K | 0.20% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 303,882 | $287.6K | 0.00% | +12,992+4.5% | Added |
| BlackRock, Inc. | 244,622 | $231.5K | 0.00% | +132,276+117.7% | Added |
| Vanguard Fiduciary Trust Co | 170,668 | $161.6K | 0.00% | +1,185+0.7% | Added |
| Captrust Financial Advisors | 90,645 | $85.8K | 0.00% | +90,645 | New |
| Northern Trust Corp | 67,735 | $64.1K | 0.00% | +37+0.1% | Added |
| First American Bank | 60,000 | $56.8K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 53,189 | $50.3K | 0.00% | +18,122+51.7% | Added |
| State Street Corp | 49,100 | $46.5K | 0.00% | 00.0% | Unchanged |